Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. Wall Street was lower after Friday’s rebound in a wild week that featured rotations in and out of tech. It’s a busy week ahead with a Fed meeting, 14 earnings … Read more
When I was a cub reporter in Los Angeles, covering crime for the now-deceased Los Angeles Herald Examiner, we used to joke that we should never let the facts get in the way of a good story. It was a horrendous paper — don’t ask me what I was doing there other than booking a … Read more
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Friday’s key moments. Stocks jumped Friday as Wall Street tried to end a turbulent week on a jubilant note. The Dow Jones Industrial Average added more more than 600 points, or 1.6%. The … Read more
Wall Street managed to finish higher this week despite Thursday’s brutal rotation out of tech stocks. The Dow Jones Industrial Average was the big winner on the week — advancing nearly 1.6% as favorable inflation data prompted investors to scoop up economic- and rate-sensitive stocks that have not done as well this year. The S … Read more
Abbott Chairman of the Board and CEO Robert B. Ford delivers a keynote address at CES 2022 at The Venetian Las Vegas on January 6, 2022 in Las Vegas, Nevada. Ethan Miller | Getty Images Abbott Laboratories announced on Monday it received approval from the U.S. Food and Drug Administration for two new continuous glucose … Read more
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday key moments. The stock market experienced a broad decline Wednesday as Club name Nvidia seesawed on either side of unchanged. Nvidia has been on a tear since last Wednesday’s blockbuster quarter — … Read more
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) No big swings : The market … Read more
Here’s our Club Mailbag email [email protected] — so you send your questions directly to Jim Cramer and his team of analysts. We can’t offer personal investing advice. We will only consider more general questions about the investment process or stocks in the portfolio or related industries. This week’s question: You advise not to buy stocks … Read more
Abbott Laboratories delivered a top and bottom line beat Wednesday and surprised investors by raising its full-year guidance — a show of confidence by the medical device maker not seen in a first quarter since 2016. Revenue for the three months ended March 31 rose slightly more than 2% year over year to $9.96 billion, … Read more
Shortly after the opening bell, we will be buying 100 shares of Abbott Laboratories at roughly $108.26. Following the trade, Jim Cramer’s Charitable Trust will own 800 shares of ABT, increasing its weighting to roughly 2.8% from 2.45%. Abbott Laboratories on Wednesday reported better-than-expected first-quarter earnings, but its stock is trading lower in the premarket, … Read more
